The 41 references in paper A. Kharitonov G., E. Kondrashina A., A. Baranovsky Yu., T. Bulgakova V., S. Lapin V., Areg Totolian A., А. Харитонов Г., Э. Кондрашина А., А. Барановский Ю., Т. Булгакова В., С. Лапин В., Арег Тотолян А. (2014) “АНТИТЕЛА К ЦИТОПЛАЗМЕ НЕЙТРОФИЛОВ КАК МАРКЕР НЕБЛАГОПРИЯТНОГО ТЕЧЕНИЯ НЕСПЕЦИФИЧЕСКОГО ЯЗВЕННОГО КОЛИТА // ANTIBODIES TO THE CYTOPLASM OF NEUTROPHILS: A MARKER OF UNFAVORABLE CLINICAL COURSE IN NON-SPECIFIC ULCERATIVE COLITIS” / spz:neicon:mimmun:y:2010:i:6:p:537-546

1
Лапин C.В., Тотолян А.А. Иммунологическая лабораторная диагностика аутоиммунных заболеваний. – СПб.: Человек, 2010. – 272 c.
(check this in PDF content)
2
Никулина И.В., Златкина А.Р., Белоусова Е.А., Румянцев В.Г. Оценка клиникоэпидемиологических показателей воспалительных заболеваний кишечника в Московской области // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. – 1997. – No 2. – C. 67-71.
(check this in PDF content)
3
Abad E., Tural C., Mirapeix E., Cuxart A. Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity // J. Autoimmun. – 1997. – Vol. 10, N 2. – P. 175-180.
(check this in PDF content)
4
Bansi D.S., Chapman R.W., Fleming K.A. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease // Eur. J. Gastroenterol. Hepatol. – 1996. – Vol. 8, N 9. – P. 881-885.
(check this in PDF content)
5
Bansi D.S., Fleming K.A., Chapman R.W. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass // Gut. – 1996. – Vol. 38, N 3. – P. 384-389.
(check this in PDF content)
6
Cohavy O., Bruckner D., Gordon L.K., Misra R., Wei B., Eggena M.E. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope // Infect. Immun. – 2000. – Vol. 68, N 3. – P. 1542-1548.
(check this in PDF content)
7
Cui M.H., Liu Y.L., Yu W.D., Li X.Y. Diagnostic value of antineutrophil cytoplasmic antibodies in patients with ulcerative colitis: a meta-analysis // Zhonghua Yi Xue Za Zhi. – 2008. – Vol. 88, N 44. – P. 3116-3119.
(check this in PDF content)
8
Falk R.J., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis // N. Engl. J. Med. – 1988. – Vol. 318, N 25. – P. 1651-1657.
(check this in PDF content)
9
Fekih M., Hlima S., Zitouni M., Matri S., Вoubaker J., Makni S., Azza F. Interest of serologic markers in inflammatory bowel disease. About 105 cases // Tunis. Med. – 2007. – Vol. 85, N 10. – P. 821-828.
(check this in PDF content)
10
Gilligan H.M., Bredy B., Brady H.R., Hbert M.J., Slayter H.S. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming // J. Exp. Med. – 1996. – Vol. 184, N 6. – P. 2231-2241.
(check this in PDF content)
11
Kallenberg C.G., Brouwer E., Weening J.J., Tervaert J.W. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential // Kidney Int. – 1994. – Vol. 46, N 1. – P. 1-15.
(check this in PDF content)
12
Leatherman J.W., Sibley R.K., Davies S.F. Diffuse intrapulmonary hemorrhage and glomerulonephritis unrelated to anti-glomerular basement membrane antibody // Am. J. Med. – 1982. – Vol. 72, N 3. – P. 401-410.
(check this in PDF content)
13
Lee J.H., Cheon J.H., Kim E.S., Chung M.J. The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis // Dig. Dis. Sci. – 2009. – P. 112-118.
(check this in PDF content)
14
Liu X., Yu T., Zhao M. The diagnostic significance of antineutrophil cytoplasmic antibodies in ulcerative colitis // Zhonghua. Nei. Ke. Za. Zhi. – 1999. – Vol. 38, N 7. – P. 451-454.
(check this in PDF content)
15
Loftus E.V. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences // Gastroenterology. – 2004. – Vol. 126, N 6. – P. 1504-1517.
(check this in PDF content)
16
Mallolas J., Esteve M., Rius E., Cabré E., Gassull M.A. Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis // Gut. – 2000. – Vol. 47, N 1. – P. 74-78.
(check this in PDF content)
17
Mokrowiecka A., Gasiorowska A., MaleckaPanas E. Assessment of usefulness of antiSaccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases // Pol. Merkur. Lekarski. – 2004. – Vol. 17. – N 1. – P. 22-26.
(check this in PDF content)
18
Mokrowiecka A., Gasiorowska A., MaleckaPanas E. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease // Hepatogastroenterology. – 2007. – Vol. 54, N 77. – P. 1443-1448.
(check this in PDF content)
19
Mulder A.H., Broekroelofs J., Horst G., Limburg P.C., Nelis G.F., Kallenberg C.G. Antineutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates // Clin. Exp. Immunol. – 1994. – Vol. 95, N 3. – P. 490-497.
(check this in PDF content)
20
Osangthamnont C., Manatsathit S., Pongprasopchai S., Viriyataveekul R., Chaihirunkarn S., Leelakusolvong S., Boonyapisit S. Antibodies to neutrophil cytoplasma in patients with ulcerative colitis and their first-degree relatives in Thailand // J. Gastroenterol. Hepatol. – 2001. – Vol. 16, N 8. – P. 866-871.
(check this in PDF content)
21
Papp M., éAltorjay I., Lakos G., Tumpek J. Evaluation of the combined application of ethanolfixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease Clin. // Vaccine Immunol. – 2009. – Vol. 16, N 4. – P. 464-470.
(check this in PDF content)
22
Peen E., Almer S., Bodemar G. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn’s disease // Gut. – 1993. – Vol. 34, N 1. – P. 56-62.
(check this in PDF content)
23
Preda C.M., Vermeire S., Rutgeerts P., Joosens S., Diculescu M., Marica C., Ciocarlan M., Mirea V., Oproiu A. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn’s disease and ulcerative colitis // Rom. J. Gastroenterol. – 2005. – Vol. 14, N 4. – P. 357-360.
(check this in PDF content)
24
Roozendaal C., Milligen W., Haagsma E.B., Horst G. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features // Am. J. Med. – 1998. – Vol. 105, N 5. – P. 393-399.
(check this in PDF content)
25
Rubin G.P., Hungin A.P., Kelly P.J., Ling J. Inflammatory bowel disease: epidemiology and management in an English general practice population // Aliment. Pharmacol. Ther. – 2000. – Vol. 14, N 12. – P. 1553-1559.
(check this in PDF content)
26
Rump J.A., Schélmerich J., Gross V., Roth M. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn’s disease // Immunobiology. – 1990. – Vol. 181, N 4-5. – Р. 406-413.
(check this in PDF content)
27
Sandborn W., Landers C., Tremaine W. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study // Mayo Clin. Proc. – 1996. – Vol. 71, N 5. – P. 431-436.
(check this in PDF content)
28
Saxon A., Shanahan F., Landers C., Ganz T., Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease // J. Allergy Clin. Immunol. – 1990. – Vol. 86, N 2. – P. 202-210.
(check this in PDF content)
29
Schnabel A., Csernok E., Isenberg D.A., Mrowka C., Gross W.L. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance // Arthritis Rheum. – 1995. – Vol. 38, N 5. – P. 633-637.
(check this in PDF content)
30
Seibold F, Slametschka D., Gregor M., Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis // Gastroenterology. – 1994. – Vol. 107, N 2. – P. 532-536.
(check this in PDF content)
31
Shanahan F., Duerr R.H., Rotter J.I., Yang H., Sutherland L.R. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity // Gastroenterology. – 1992. – Vol. 103, N 2. – P. 456-461.
(check this in PDF content)
32
Sobajima J., Ozaki S., Okazaki T. Antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type // Clin. Exp. Immunol. – 1996. – Vol. 105, N 1. – P. 120-124.
(check this in PDF content)
33
Sobajima J., Ozaki S., Osakada F., Uesugi H., Shirakawa H., Yoshida M., Nakao K. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2 // Clin. Exp. Immunol. – 1997. – Vol. 107, N 1. – P. 135-140.
(check this in PDF content)
34
Solberg I.C., Lygren I., Cvancarova M., Jahnsen J., Stray N., Sauar J. Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease // Inflamm. Bowel. Dis. – 2009. – Vol. 15, N3. – P. 406-414.
(check this in PDF content)
35
Stange E.F., Travis S.P.L., Vermeire S., Reinisch W. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis Journal of Crohn’s and Colitis. – 2008. – Vol. 2, N 1. – P. 1-23.
(check this in PDF content)
36
Targan S.R., Landers C.J., Cobb L., MacDermott R.P., Vidrich A. Perinuclear antineutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients // J. Immunol. – 1995. – Vol. 155, N 6. – P. 3262-3267.
(check this in PDF content)
37
Terjung B., Spengler U., Sauerbruch T., Worman H. J. “Atypical p-ANCA” in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines // Gastroenterology. – 2000. – Vol. 119, N 2. – P. 310-322.
(check this in PDF content)
38
Uesugi H., Ozaki S., Sobajima J. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases // J. Rheumatol. – 1998. – Vol. 25, N 4. – P. 703-709.
(check this in PDF content)
39
Vergara T., Cofr P., Cifuentes S., Pulgar U., Puebla C., Velasco S. Presence of antineutrophil cytoplasmic antibodies (ANCA) and anti Saccharomyces cerevisiae antibodies (ASCA) among patients with ulcerative colitis // Rev. Med. Chil. – 2006. – Vol. 134, N 8. – P. 960-964.
(check this in PDF content)
40
Yang S.K., Hong W.S., Min Y.I. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 19861997 // J. Gastroenterol. Hepatol. – 2000. – Vol. 15, N 9. – P. 1037-1042.
(check this in PDF content)
41
Woude F.J. Anticytoplasmic antibodies in Wegener’s granulomatosis // Lancet. – 1985. – Vol. 6, N 2. – P. 8445-8448. поступила в редакцию 10.09.2010 принята к печати 05.11.2010
(check this in PDF content)